EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›HWKN

HWKN

HAWKINS INC

Next earnings Jul 28, 2026 · consensus $1.44 EPS, $320M rev

Last earnings -4.0% on 2026-05-13

Hold
$161.59
▼ -2.37%
$161.59▲ +16.10%
over 1Y
L $119.87EODHDH $183.81
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-2.4%
1W-0.3%
1M+2.0%
3M+6.4%
YTD+11.5%
1Y+16.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 9 analysts
Buy

Quality specialty-chemicals transformation, but FY26 EPS slipped while the multiple stayed rich — own it, don't add up here.

Revenue $1.08B · FY2026

The read

Middling fundamentals and a rich price (~65% above fair value) leave little margin of safety — a wait-and-see.

Hawkins is a real business in transition: management is deliberately repositioning from a 'bulk commodity distributor into a specialty ingredients company,' realigning into three new segments and spending aggressively to get there. FY26 revenue jumped 11.2% to $1.08B and operating cash flow surged 29.9% to $144M, but GAAP diluted EPS actually fell 3.0% to $3.91 — the first earnings decline after three years of clean expansion ($51.5M → $60.0M → $75.4M → $84.3M → $81.5M). Management points to pro-forma diluted EPS of $3.95 (+9%) to bridge the gap, which tells you acquisition/integration drag is the culprit, not core demand.

Financials · annual, by fiscal year

Line itemFY22FY23FY24FY25FY26
Revenue$775M$935M$919M$974M$1.08B
Gross profit$147M$165M$194M$226M$245M
Operating income$71.2M$88.2M$104M$119M$121M
Net income$51.5M$60.0M$75.4M$84.3M$81.5M
Diluted EPS$2.44$2.86$3.59$4.03$3.91
Net margin6.7%6.4%8.2%8.7%7.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.62B
EV / EBITDA20.8
EV / Sales3.3
EV / FCF42.1
P / FCF39.2
PEG (trailing)—
Earnings yield2.4%
FCF yield2.6%

Quality & risk

ROIC (est.)12.2%
Free cash flow$86.1M
Total debt$254M
Net cash-$250M
Altman Z-Score6.84 safe
Piotroski F-Score3/9

Capital returns

Buyback yield—
Dividend yield (est.)0.5%
Shareholder yield0.5%
Shares Δ YoY+0.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. DEF 14A Proxy statement2026-06-18

    Annual proxy: routine director elections, auditor ratification, say-on-pay

  2. 8-K Officer / director change2026-05-19

    Officer/director change (Item 5.02); no financial impact disclosed

  3. 8-K Earnings results2026-05-13

    FY26: sales +11%, OCF +30%, but EPS -3% on $150M WaterSurplus deal dilution

  4. 10-K Annual report2026-05-13

    FY26: sales +11%, OCF +30%, but EPS -3% on $150M WaterSurplus deal dilution

  5. 8-K Earnings results2026-01-28

    Q3 FY26 results reflecting acquisition-driven growth and segment realignment

  6. 10-Q Quarterly report2026-01-28

    Q3 FY26 results reflecting acquisition-driven growth and segment realignment

  7. 8-K Officer / director change2025-12-19

    Executive officer change announcement (Item 5.02)

  8. 8-K Earnings results2025-10-29

    Q2 FY26: WaterSurplus integration in full swing; debt rising to fund M&A

  9. 10-Q Quarterly report2025-10-29

    Q2 FY26: WaterSurplus integration in full swing; debt rising to fund M&A

Recent filings

all on EDGAR ↗
ARSPeriod ending 2026-03-292026-06-18open ↗DEFA14AFiling2026-06-18open ↗DEF 14APeriod ending 2026-03-292026-06-18open ↗3Period ending 2026-05-132026-05-20open ↗8-KPeriod ending 2026-05-132026-05-19open ↗4Period ending 2026-03-302026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueC-
GrowthC-
ProfitabilityB-
Financial healthA-
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$56.39

Overvalued -65% vs price

cheapfair valueexpensive

Modified Graham: EPS $3.91 × (8.5 + 1.5 × 3.9% growth) × 1.00 quality = 14.4× multiple. An estimate, not a price target.

Revenue
$1.08B
+11.2% YoY
Net margin
7.5%
ROE
15.3%
P/E
41.3

SEC fundamentals · FY 2026

'22'23'24'25'26

■ revenue · ■ net income, by fiscal year

Revenue$1.08B+11.2%
Net income$81.5M-3.3%
Gross profit$245M+8.7%
Operating income$121M+1.8%
Diluted EPS$3.91-3.0%
Cash & equivalents$3.91M-23.3%
Total assets$986M+28.1%
Total liabilities$452M+46.0%
Stockholders' equity$534M+16.0%
Gross: 22.6%Op.: 11.2%L/E: 0.85x

Frequently asked

Is HAWKINS INC (HWKN) a buy?
HWKN currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Quality specialty-chemicals transformation, but FY26 EPS slipped while the multiple stayed rich — own it, don't add up here.
What is HWKN's fair value?
A Modified-Graham model based on HWKN's SEC fundamentals estimates a fair value of about $56.39. It is an estimate from reported earnings, not a price target.
Is HWKN overvalued or undervalued?
Against a Modified-Graham fair-value estimate, HWKN currently appears overvalued relative to its SEC-grounded earnings power.
What is HAWKINS INC's quality score?
HWKN scores 63.09803921568627/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000046250, latest 10-K filed 2026-05-13) · EODHD · analysis by claude-code · as of 6/25/2026, 1:33:26 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-13
Rozeboom Shirley A.
VP HEALTH AND NUTRITION
Award1.91K
2026-05-13
Lange Douglas A.
VP - WATER TREATMENT GROUP
Award1.99K
2026-05-13
Oldenkamp Jeffrey P.
EXECUTIVE VP AND CFO
Award8.44K
2026-05-13
Grahek Drew M.
VICE PRESIDENT OF OPERATIONS
Award2.70K
2026-05-13
Mangine David J.
VP-INDUSTRIAL SOLUTIONS GROUP
Award1.91K
2026-05-13
Jones Gregory Alan
VP of Food and Health Sciences
Award1.97K
2026-05-13
Hawkins Patrick H.
CEO AND PRESIDENT
Award16.9K
2026-03-30
Rozeboom Shirley A.
VP HEALTH AND NUTRITION
Tax3.61K @ $151.62$547K
2026-03-30
Lange Douglas A.
VP - WATER TREATMENT GROUP
Tax3.85K @ $151.62$584K

Dividends

Quarterly
Yield (TTM)
0.5%
Annual / share
$0.76
Last ex-date
2026-05-29
Last amount
$0.19
ex 2026-05-29paid 2026-06-12$0.19
ex 2026-02-13paid 2026-02-27$0.19
ex 2025-11-14paid 2025-11-28$0.19
ex 2025-08-15paid 2025-08-29$0.19
ex 2025-05-30paid 2025-06-13$0.18
ex 2025-02-14paid 2025-02-28$0.18

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-13Miss -5.0% est▼ -4.01%8-K ↗
2026-01-28Miss -9.1% est▲ +0.07%8-K ↗
2025-10-29Miss -13.1% est▼ -4.02%8-K ↗
2025-07-30Beat +3.4% est▼ -0.92%8-K ↗
2025-05-14—▼ -0.52%8-K ↗
2025-01-29—▼ -0.25%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
FUPBY or HWKN: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-06-25
FUPBY vs. HWKN: Which Stock Is the Better Value Option?Bullish
finance.yahoo.com· 2026-06-09
FUL or HWKN: Which Is the Better Value Stock Right Now?Bullish
finance.yahoo.com· 2026-05-20
Is It Too Late To Consider Hawkins (HWKN) After Its Strong Multi Year Share Price Run?Bullish
finance.yahoo.com· 2026-05-15
Hawkins (HWKN) Q4 Earnings Miss EstimatesBullish
finance.yahoo.com· 2026-05-13
Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2026 ResultsBullish
finance.yahoo.com· 2026-05-13

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score63 vs 67
Revenue growth11.2% vs 7.1%
Net margin7.5% vs 10.5%
Return on equity15.3% vs 12.3%
P/E41.3 vs 25.5

News sentiment

EODHD · 15d
Bullish
+0.17
vs typical · 34 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.